Brief: Maravai LifeSciences Sees FY revenue USD 400-440 million
08/05/2023 22:31
May 8 (Reuters) - Maravai LifeSciences Outlook FY revenue USD 400-440 million. * Outlook FY adjusted EPS USD 0.27-0.33 * Outlook FY adjusted EBITDA USD 155-175 million * Q1 adjusted EPS USD 0.03
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million